Your browser doesn't support javascript.
loading
TOLLIP Single Nucleotide Polymorphism and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.
Whalen, William; Berger, Kristin; Kim, John S; Simmons, Will; Ma, Shwu-Fan; Kaner, Robert J; Martinez, Fernando J; Anstrom, Kevin J; Parfrey, Helen; Maher, Toby; Hammond, Matt; Clark, Allan B; Thickett, David; Jenkins, R Gisli; Wilson, Andrew M; Noth, Imre.
Afiliación
  • Whalen W; Weill Cornell Medical College, 12295, Department of Medicine, Division of Pulmonary and Critical Care, New York, New York, United States; wmw9004@med.cornell.edu.
  • Berger K; Weill Cornell Medical College, 12295, Department of Medicine, Division of Pulmonary and Critical Care, New York, New York, United States.
  • Kim JS; University of Virginia School of Medicine, 12349, Department of Medicine, Charlottesville, Virginia, United States.
  • Simmons W; Weill Cornell Medicine, 12295, Department of Population Health Sciences, New York, New York, United States.
  • Ma SF; University of Virginia, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Charlottesville, Virginia, United States.
  • Kaner RJ; Weill Cornell Medical College, Pulmonary and Critical Care Medicine; Genetic Medicine, New York, New York, United States.
  • Martinez FJ; Weill Cornell Medical College, 12295, Department of Medicine, Division of Pulmonary and Critical Care, New York, New York, United States.
  • Anstrom KJ; University of North Carolina at Chapel Hill Gillings School of Global Public Health, 41474, Chapel Hill, North Carolina, United States.
  • Parfrey H; Cambridge Regional Interstitial Lung Disease Service, Papworth and Addenbrooke\'s Hospitals, Cambridge, United Kingdom of Great Britain and Northern Ireland.
  • Maher T; University of Southern California Keck School of Medicine, 12223, PCCSM, Los Angeles, California, United States.
  • Hammond M; University of East Anglia, Norwich Clinical Trials Unit, Norwich, United Kingdom of Great Britain and Northern Ireland.
  • Clark AB; University of East Anglia Norwich Medical School, 12201, Norwich, United Kingdom of Great Britain and Northern Ireland.
  • Thickett D; University of Birmingham, Lung Injury and Fibrosis Treatment Programme, Birmingham, United Kingdom of Great Britain and Northern Ireland.
  • Jenkins RG; Imperial College London, 4615, National Heart & Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.
  • Wilson AM; NIHR Nottingham Biomedical Research Centre, 574111, Respiratory Research Unit, Nottingham, Nottinghamshire, United Kingdom of Great Britain and Northern Ireland.
  • Noth I; University of Nottingham School of Medicine, 170718, Division of Respiratory Medicine, Nottingham, United Kingdom of Great Britain and Northern Ireland.
Am J Respir Crit Care Med ; 2024 May 19.
Article en En | MEDLINE | ID: mdl-38762791
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2024 Tipo del documento: Article